Results 261 to 270 of about 515,791 (281)

Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial

Lancet Oncology, The, 2020
Shaji K Kumar, Simon J Harrison, Michele Cavo   +2 more
exaly  

Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study

Lancet, The, 2019
Paul G Richardson, S Vincent Rajkumar, Jesus San Miguel   +2 more
exaly  

Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial

Lancet, The, 2016
Corinne Faivre-Finn, Elaine McColl
exaly  

Dexamethasone induction of hypertension and diabetes is PPAR-α dependent in LDL receptor–null mice

Nature Medicine, 2003
Carlos Bernal-Mizrachi, Brian N Finck, Russell H Knutsen   +2 more
exaly  

Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial

Lancet Oncology, The, 2013
Jesus San Miguel, Katja C Weisel, Phillipe Moreau   +2 more
exaly  

Dexamethasone

Reactions, 1988
openaire   +1 more source

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

Lancet Oncology, The, 2019
Paul G Richardson, Albert Oriol
exaly  

Effects of dexamethasone on early cognitive decline after cardiac surgery: A randomised controlled trial

European Journal of Anaesthesiology, 2017
Sandro Glumac, G. Kardum, Lidija Šodić, Daniela Šupe-Domić, N. Karanović   +4 more
semanticscholar   +1 more source

Dexamethasone

Reactions Weekly, 2015
openaire   +2 more sources

Phase III Clinical Trial of Thalidomide Plus Dexamethasone Compared With Dexamethasone Alone in Newly Diagnosed Multiple Myeloma: A Clinical Trial Coordinated by the Eastern Cooperative Oncology Group

Journal of Clinical Oncology, 2006
S Vincent Rajkumar, Rafael Fonseca
exaly